Straits Research Pvt Ltd
A2 Milk Market Size is Projected to Reach USD 5.06 Billion by 2030: Top Competitive Players GCMMF (Amul), Erden Creamery Private Limited, Freedom Foods Group Limited etc.
September 05, 2022 16:10 ET | Straits Research
New York, United States, Sept. 05, 2022 (GLOBE NEWSWIRE) -- A2 milk is a cow's milk primarily composed of the A2 beta-casein protein and does not contain the A1 beta-casein protein. A2 milk is a...
22157.jpg
Global Food Allergy and Intolerance Products Market Report 2021: Market to Reach $32 Billion by 2027 - Broad Availability of Products Encourage Market Growth
August 09, 2021 08:08 ET | Research and Markets
Dublin, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The "Food Allergy and Intolerance Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Amazon Now Carries RelSup Dietary Supplements
November 18, 2020 10:01 ET | RelSup
PALM BEACH, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Amazon, the largest online retailer, now carries Relsup’s dietary supplements. “The RelSup team is excited that Amazon now offers our flagship...
RelSup - Reliable Supplements That You Can Trust - Now on Sale at VitaBeauti.com
September 03, 2020 15:02 ET | Nutritional Products International
BOCA RATON, FL, Sept. 03, 2020 (GLOBE NEWSWIRE) -- RelSup’s proprietary nutritional supplements for the liver, digestion, metabolic health, and lactose intolerance are now available at...
RelSup - Reliable Supplements That You Can Trust
August 26, 2020 17:41 ET | RelSup
BOCA RATON, FL, Aug. 26, 2020 (GLOBE NEWSWIRE) -- RelSup, a nutraceutical company in Minnesota, announced this week it is introducing four new dietary supplements to support liver function,...
ritter.jpg
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2019 and Provides Business Update
November 13, 2019 19:35 ET | Ritter Pharmaceuticals, Inc.
LOS ANGELES, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut...
ritter.jpg
Ritter Pharmaceuticals Reports Top-Line Results from its Liberatus Phase 3 Trial of RP-G28 for Lactose Intolerance
September 12, 2019 16:15 ET | Ritter Pharmaceuticals, Inc.
LOS ANGELES, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that...
ritter.jpg
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
July 11, 2019 17:28 ET | Ritter Pharmaceuticals, Inc.
Ritter Shares Will Continue to Trade on the Nasdaq Capital Market LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the...
ritter.jpg
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
July 02, 2019 09:00 ET | Ritter Pharmaceuticals, Inc.
Top-line Data Readout Remains on Track for early Q4 2019 LOS ANGELES, July 02, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a...
ritter.jpg
Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
May 07, 2019 09:15 ET | Ritter Pharmaceuticals, Inc.
Top-line Data Readout on Target for early Q4 2019 LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a...